Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Up – What’s Next?

Posted by Doug Wharley on Jun 30th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $11.37, but opened at $11.84. Fresenius SE & Co. shares last traded at $11.2950, with a volume of 11,915 shares traded.

Analyst Ratings Changes

Separately, Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a research note on Tuesday, June 23rd. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy”.

Check Out Our Latest Stock Report on FSNUY

Fresenius SE & Co. Price Performance

The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.98 and a current ratio of 1.27. The company has a market capitalization of $25.97 billion, a price-to-earnings ratio of 15.37 and a beta of 0.64. The company has a 50-day moving average price of $11.47 and a 200-day moving average price of $13.14.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.09%. The firm had revenue of $6.75 billion during the quarter, compared to analyst estimates of $6.79 billion. On average, equities research analysts expect that Fresenius SE & Co. will post 1.03 EPS for the current fiscal year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.